Literature DB >> 7981153

Acid sphingomyelinase is not essential for the IL-1 and tumor necrosis factor receptor signaling pathway leading to NFkB activation.

K Kuno1, K Sukegawa, Y Ishikawa, T Orii, K Matsushima.   

Abstract

A recent report has suggested that tumor necrosis factor (TNF) utilizes acid sphingomyelinase (SMase) pathway to activate NFkB (Schutze et al. 1992. Cell 71:765). To directly investigate the role of acid SMase in IL-1 and TNF receptor-mediated signal transduction, we examined the ability of Niemann-Pick disease (NPD) type A fibroblasts, which are deficient in acid SMase, to induce IL-8 gene expression through activating NFkB. Unexpectedly, IL-1 alpha and TNF-alpha efficiently induced IL-8 production and IL-8 mRNA in NPD type A fibroblasts as in normal fibroblasts. Furthermore, activation of NFkB was also induced in NPD type A fibroblasts in response to IL-1 alpha and TNF-alpha stimulation to a similar extent as in normal fibroblasts. These results provide evidence that acid SMase is not essential in IL-1 and TNF receptor signaling leading to NFkB activation as well as the cytokine gene activation which is regulated by NFkB.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981153     DOI: 10.1093/intimm/6.8.1269

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  11 in total

Review 1.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

Authors:  Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

2.  Transforming Growth Factor-β1 (TGF-β1) Driven Epithelial to Mesenchymal Transition (EMT) is Accentuated by Tumour Necrosis Factor α (TNFα) via Crosstalk Between the SMAD and NF-κB Pathways.

Authors:  Lee A Borthwick; Aaron Gardner; Anthony De Soyza; Derek A Mann; Andrew J Fisher
Journal:  Cancer Microenviron       Date:  2011-07-27

3.  Stimulation of the ceramide pathway partially mimics lipopolysaccharide-induced responses in murine peritoneal macrophages.

Authors:  S A Barber; G Detore; R McNally; S N Vogel
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5.

Authors:  Benjamin Newcomb; Cosima Rhein; Izolda Mileva; Rasheed Ahmad; Christopher J Clarke; Justin Snider; Lina M Obeid; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-05-03       Impact factor: 5.922

5.  TNF-{alpha} plays a role in hepatocyte apoptosis in Niemann-Pick type C liver disease.

Authors:  Victoria M Rimkunas; Mark J Graham; Rosanne M Crooke; Laura Liscum
Journal:  J Lipid Res       Date:  2008-09-24       Impact factor: 5.922

6.  Induction of stress-activated protein kinases/c-Jun N-terminal kinases by the p55 tumour necrosis factor receptor does not require sphingomyelinases.

Authors:  D Adam; A Ruff; A Strelow; K Wiegmann; M Krönke
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

7.  The tumour necrosis factor-sensitive pool of sphingomyelin is resynthesized in a distinct compartment of the plasma membrane.

Authors:  N Andrieu-Abadie; S Carpentier; R Salvayre; T Levade
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

8.  Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway.

Authors:  G S Dbaibo; D K Perry; C J Gamard; R Platt; G G Poirier; L M Obeid; Y A Hannun
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

9.  The effects of 6-gingerol on proliferation, differentiation, and maturation of osteoblast-like MG-63 cells.

Authors:  J Z Fan; X Yang; Z G Bi
Journal:  Braz J Med Biol Res       Date:  2015-04-28       Impact factor: 2.590

10.  Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases.

Authors:  Yue-Hong Chen; Rong-Han Liu; Ya-Zhou Cui; Aubryanna Hettinghouse; Wen-Yu Fu; Lei Zhang; Chen Zhang; Chuan-Ju Liu
Journal:  Arthritis Res Ther       Date:  2022-01-19       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.